Immobilised whole-cell recombinant monoamine oxidase biocatalysis
- 799 Downloads
This work demonstrates the first example of the immobilisation of MAO-N whole cells to produce a biocatalyst that remained suitable for repetitive use after 11 months of storage and stable up to 15 months after immobilisation. The production of Escherichia coli expressing recombinant MAO-N was scaled up to bioreactors under regulated, previously optimised conditions (10 % DO, pH 7), and the amount of biomass was almost doubled compared to flask cultivation. Subsequently, pilot immobilisation of the whole-cell biocatalyst using LentiKats® technology was performed. The amount of the immobilised biomass was optimised and the process was scaled up to a production level by immobilising 15 g of dry cell weight per litre of polyvinyl alcohol to produce 3 kg of whole-cell ready-to-use biocatalyst. The immobilised biocatalyst retained its initial activity over six consecutive biotransformations of the secondary amine model compound 3-azabicylo [3,3,0]octane, a building block of the hepatitis C drug telaprevir. Consecutive cultivation cycles in growth conditions not only increased the initial specific activity of biocatalyst produced on the industrial plant by more than 30 %, but also significantly increased the rate of the biotransformation compared to the non-propagated biocatalyst.
KeywordsImmobilisation E. coli MAO-N Biotransformation Amine
The research leading to these results has received funding from the European Union Seventh Framework Programme BIONEXGEN under grant agreement no. 266025. This work was co-funded by the Slovak Research and Development Agency under contract no. DO7RP-0042-11.
- Alexeeva M, Enright A, Dawson MJ, Mahmoudian M, Turner NJ (2002) Deracemization of α-methylbenzylamine using an enzyme obtained by in vitro evolution. Angew Chem Int Ed Engl 41:3177–3180. doi: 10.1002/1521-3773(20020902)41:17<3177::aid-anie3177>3.0.co;2-p PubMedCrossRefGoogle Scholar
- Li T, Liang J, Ambrogelly A, Brennan T, Gloor G, Huisman G, Lalonde J, Lekhal A, Mijts B, Muley S, Newman L, Tobin M, Wong G, Zaks A, Zhang XY (2012) Efficient, chemoenzymatic process for manufacture of the boceprevir bicyclic [3.1.0] proline intermediate based on amine oxidase-catalyzed desymmetrization. J Am Chem Soc 134:6467–6472PubMedCrossRefGoogle Scholar
- Stloukal R, Rosenberg M, Rebros M (2007) A method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production WO/2007/104268Google Scholar
- Voulgaris I, Arnold SA, Speight R, Harvey LM, McNeil B (2011) Effects of dissolved oxygen availability and culture biomass at induction upon the intracellular expression of monoamine oxidase by recombinant E. coli in fed batch bioprocesses. Process Biochem 46:721–729. doi: 10.1016/j.procbio.2010.11.019 CrossRefGoogle Scholar
- www.lentikats.eu; Accessed 22.5. 2014